HCI
HCI Group, Inc.
HCI has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
HCI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
HCI's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HCI.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
HCI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 7.7x | $191 | — |
| Cheap | 8.8x | $217 | +14% |
| Forward | 9.3x | $191 | — |
| Fair | 15x | $382 | +100% |
| Expensive | 30x | $752 | +294% |
Historical ranges are pointers, not guarantees.
HCI has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
HCI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect HCI's revenue to grow, but its profitability to weaken.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over HCI on the outlook, with more favorable valuation and earnings expectations.
HCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.61 | -17% |
| Q3 2026 | $24.75 | +58% |
| Q2 2026 | $23.20 | +106% |
| Q1 2026 | $22.78 | +120% |
| Q4 2025 | $22.68 | +158% |
| Q3 2025 | $15.66 | +31% |
| Q2 2025 | $11.28 | -12% |
| Q1 2025 | $10.34 | +5.2% |
| Q4 2024 | $8.80 | +16% |
HCI earned $24.75 per share over the past year, up 58% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
HCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $244.9M | +13% |
| Q2 2026 | $246.7M | +11% |
| Q1 2026 | $242.9M | +12% |
| Q4 2025 | $246.2M | +52% |
| Q3 2025 | $216.4M | +23% |
| Q2 2025 | $221.9M | +7.6% |
| Q1 2025 | $216.4M | +4.8% |
| Q4 2024 | $161.9M | -0.5% |
HCI has the edge over JPM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +5.6 points |
| Q2 2026 | 45% | +2.5 points |
| Q1 2026 | 48% | +1.1 points |
| Q4 2025 | 58% | +55 points |
| Q3 2025 | 42% | +34 points |
| Q2 2025 | 43% | +5.7 points |
| Q1 2025 | 46% | +8.9 points |
| Q4 2024 | 3.6% | -30 points |
HCI has the edge over JPM on profitability, with a higher operating margin.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
HCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $74.5M | +188% |
| Q2 2026 | $124.8M | -14% |
| Q1 2026 | $148.5M | -7.4% |
| Q4 2025 | $110.2M | +50% |
| Q3 2025 | $25.9M | -75% |
| Q2 2025 | $144.5M | +$174.6M |
| Q1 2025 | $160.3M | -11% |
| Q4 2024 | $73.6M | -52% |
HCI has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
HCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -95K shares |
| 1 year | -2.6% | -329K shares |
| 3 years | +42% | +3.7M shares |
HCI has 13M diluted shares, down 2.6% from a year ago, with $81M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5.5M |
| Q2 2026 | $57M |
| Q1 2026 | $17.5M |
| Q4 2025 | $800,000 |
| Q3 2025 | $37,000 |
| Q2 2025 | $48,000 |
| Q1 2025 | $639,000 |
| Q4 2024 | — |
HCI spent $81M buying back its own shares over the past year, more than ten times what it spent the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over HCI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
HCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q2 2026 | -1.8x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -2.7x | Net Cash |
| Q3 2025 | -3.2x | Net Cash |
| Q2 2025 | -4.1x | Net Cash |
| Q1 2025 | -3.5x | Net Cash |
| Q4 2024 | -2.7x | Net Cash |
HCI has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
HCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.5 | Neutral |
| Stochastic | 51.9 | Neutral |
HCI's weekly RSI is 55 (neutral) and its Stochastic is 52 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
HCI PE vs Financial Services Sector
| Metric | HCI | Sector median | Relative |
|---|---|---|---|
| PE | 7.7x | 13x | 41% below |
| PE % | 9 | 63 | 54 pts below |
HCI has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
HCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $191.0 | 0.1% below |
| 20 week MA | $186.4 | 2.4% above |
| 50 week MA | $173.3 | 10% above |
| 100 week MA | $162.9 | 17% above |
| 200 week MA | $122.1 | 56% above |
HCI's trend is up, with a small recent dip: it's below only its 8-week average, and 56% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
HCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $45.9 | $51.8 | +13% |
| 2021 | $51.8 | $87.5 | +69% |
| 2022 | $87.5 | $39.6 | -55% |
| 2023 | $39.6 | $87.4 | +121% |
| 2024 | $87.4 | $117.4 | +34% |
| 2025 | $117.4 | $192.1 | +64% |
| 2026 YTD | $192.1 | $190.8 | -0.6% |
HCI's yearly returns have swung widely, from +121% in 2023 to −55% in 2022. It's down 0.6% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over HCI on returns for 2026, with the stronger performance.